{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:11:51Z","timestamp":1760911911413,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.cyto.2022.155874","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T03:37:33Z","timestamp":1649043453000},"page":"155874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pro-inflammatory immune profile mediated by TNF and IFN-\u03b3 and regulated by IL-10 is associated to IgG anti-SARS-CoV-2 in asymptomatic blood donors"],"prefix":"10.1016","volume":"154","author":[{"given":"Daniel Gon\u00e7alves","family":"Chaves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo Camilo","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Clara Fernandes","family":"da Silva Malta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle Rocha","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edel Figueiredo","family":"Barbosa-Stancioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro Martins","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina Lobato","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cyto.2022.155874_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/JCMA.0000000000000270","article-title":"The outbreak of COVID-19: An overview","volume":"83","author":"Wu","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"issue":"3","key":"10.1016\/j.cyto.2022.155874_b0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev.Microbiol."},{"key":"10.1016\/j.cyto.2022.155874_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.581338","article-title":"Pro- and anti-inflammatory responses in severe COVID-19-induced acute respiratory distress syndrome \u2013 an observational pilot study","volume":"11","author":"Notz","year":"2020","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155874_b0020","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/21505594.2021.1898790","article-title":"Immune dysregulation and system pathology in COVID-19","volume":"12","author":"Jamal","year":"2021","journal-title":"Virulence"},{"issue":"115","key":"10.1016\/j.cyto.2022.155874_b0025","doi-asserted-by":"crossref","first-page":"e200342","DOI":"10.1590\/0074-02760200342","article-title":"SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network","volume":"23","author":"Ara\u00fajo","year":"2020","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"10","key":"10.1016\/j.cyto.2022.155874_b0030","doi-asserted-by":"crossref","first-page":"e0241104","DOI":"10.1371\/journal.pone.0241104","article-title":"Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders","volume":"15","author":"Marklund","year":"2020","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.cyto.2022.155874_b0035","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/s41564-020-00813-8","article-title":"Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans","volume":"5","author":"Seow","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.cyto.2022.155874_b0040","article-title":"Progression and predictors of SARS-CoV-2 antibody seroreactivity in US blood donors","volume":"30","author":"Vassallo","year":"2021","journal-title":"Transfus. Med. Rev."},{"issue":"12","key":"10.1016\/j.cyto.2022.155874_b0045","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.cmi.2021.09.019","article-title":"Update on SARS-CoV-2 seroprevalence: regional and worldwide","volume":"27","author":"Rostami","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cyto.2022.155874_b0050","doi-asserted-by":"crossref","unstructured":"M.K. Young, C. Kornmeier, R.M. Carpenter, N.R. Natale, J.M. Sasson, M.D. Solga, A.J. Mathers, M.D. Poulter, X. Qiang, W.A. Petri, IgG antibodies against SARS-CoV-2 correlate with days from symptom onset, viral load and IL-10. medRxiv [Preprint]. 2020 Dec 7:2020.12.05.20244541.","DOI":"10.1101\/2020.12.05.20244541"},{"issue":"2","key":"10.1016\/j.cyto.2022.155874_b0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","article-title":"COVID-19-neutralizing antibodies predict disease severity and survival","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2022.155874_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","article-title":"Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum","volume":"22","author":"Weisberg","year":"2021","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2022.155874_b0065","first-page":"e214302","article-title":"Association of age with SARS-CoV-2 antibody response","volume":"4","author":"Yang","year":"2021","journal-title":"JAMANetw Open."},{"issue":"5","key":"10.1016\/j.cyto.2022.155874_b0070","doi-asserted-by":"crossref","first-page":"e2025","DOI":"10.1210\/clinem\/dgab004","article-title":"Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health","volume":"106","author":"Racine-Brzostek","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2022.155874_b0075","doi-asserted-by":"crossref","unstructured":"V. De Giorgi, K.A. West, A.N. Henning, L. Chen, M.R. Holbrook, R. Gross, J. Liang, E. Postnikova, J. Trenbeath, S. Pogue, T. Scinto, H.J. Alter, C.C. Cantilena, Anti-SARS-CoV-2 serology persistence over time in COVID-19 convalescent plasma donors. medRxiv [Preprint]. 2021 Mar 10:2021.03.08.21253093.","DOI":"10.1101\/2021.03.08.21253093"},{"issue":"5","key":"10.1016\/j.cyto.2022.155874_b0080","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s11357-021-00443-w","article-title":"Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort-correlation with disease characteristics","volume":"43","author":"Schmidt","year":"2021","journal-title":"Geroscience"},{"issue":"1","key":"10.1016\/j.cyto.2022.155874_b0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/21645515.2020.1787074","article-title":"Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development","volume":"17","author":"Cohen","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.cyto.2022.155874_b0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41467-020-20247-4","article-title":"Neutralizing antibody titres in SARS-CoV-2 infections","volume":"12","author":"Lau","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cyto.2022.155874_b0095","doi-asserted-by":"crossref","first-page":"ofaa574","DOI":"10.1093\/ofid\/ofaa574","article-title":"Cytokine and chemokine levels in coronavirus disease 20*19 convalescent plasma","volume":"8","author":"Bonny","year":"2020","journal-title":"Open Forum Infect. Dis."},{"issue":"6","key":"10.1016\/j.cyto.2022.155874_b0100","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.4269\/ajtmh.20-1110","article-title":"Factors of severity in patients with COVID-19: Cytokine\/chemokine concentrations, viral load, and antibody responses","volume":"103","author":"Kwon","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.cyto.2022.155874_b0105","first-page":"1","article-title":"Pro-inflammatory CXCL-10, TNF-\u03b1, IL-1\u03b2, and IL-6: biomarkers of SARS-CoV-2 infection","author":"Tripathy","year":"2021","journal-title":"Arch Virol."},{"issue":"6","key":"10.1016\/j.cyto.2022.155874_b0110","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the inflammatory response to severe COVID-19 illness","volume":"202","author":"McElvaney","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.cyto.2022.155874_b0115","doi-asserted-by":"crossref","first-page":"e01324","DOI":"10.1128\/mSphere.01324-20","article-title":"Interplay of antibody and cytokine production reveals CXCL13 as a potential novel biomarker of lethal SARS-CoV-2 infection","volume":"6","author":"Horspool","year":"2021","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.cyto.2022.155874_b0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19","volume":"26","author":"Chen","year":"2020","journal-title":"Mol. Med."},{"issue":"13","key":"10.1016\/j.cyto.2022.155874_b0125","first-page":"7497","article-title":"CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients","volume":"24","author":"Zhang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6294","key":"10.1016\/j.cyto.2022.155874_b0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/347669a0","article-title":"Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES","volume":"347","author":"Schall","year":"1990","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cyto.2022.155874_b0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jlb.61.3.246","article-title":"Mig and IP-10: CXC chemokines that target lymphocytes","volume":"61","author":"Farber","year":"1997","journal-title":"J. Leukoc. Biol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:43:31Z","timestamp":1760910211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466622000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":27,"alternative-id":["S1043466622000837"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155874","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-inflammatory immune profile mediated by TNF and IFN-\u03b3 and regulated by IL-10 is associated to IgG anti-SARS-CoV-2 in asymptomatic blood donors","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155874"}}